Literature DB >> 34275006

Increased subcortical region volume induced by electroconvulsive therapy in patients with schizophrenia.

Xiaoxiao Shan1, Haisan Zhang2,3, Zhao Dong2,4, Jindong Chen1, Feng Liu5, Jingping Zhao1, Hongxing Zhang6,7,8, Wenbin Guo9,10.   

Abstract

Electroconvulsive therapy (ECT) has been widely used to treat patients with schizophrenia. However, the underlying mechanisms of ECT remain unknown. In the present study, the treatment effects of ECT on brain structure in patients with schizophrenia were explored. Seventy patients with schizophrenia were scanned using structural magnetic resonance imaging. Patients in the drug group were scanned at baseline (time 1) and follow-up (time 2, 6 weeks of treatment). Patients in the ECT group were scanned before ECT treatment (baseline, time 1) and 10-12 h after the last ECT treatment (time 2). Voxel-based morphometry was applied to analyze the imaging data. Patients in the ECT group showed significantly increased gray matter volume (GMV) in the bilateral hippocampus/amygdala and left superior temporal gyrus (STG)/middle temporal gyrus (MTG) after ECT combined with antipsychotic therapy at time 2. In contrast, patients in the drug group showed decreased GMV in widespread brain regions. Correlation analysis results showed significantly negative correlations between the increased GMV in the bilateral hippocampus/amygdala and PANSS scores at baseline in the ECT group. ECT may modulate brain structure in patients with schizophrenia. The GMV in distinct subcortical regions was related to the individual therapeutic response in patients with schizophrenia.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Electroconvulsive therapy; Grey matter volume; Magnetic resonance imaging; Schizophrenia

Mesh:

Year:  2021        PMID: 34275006     DOI: 10.1007/s00406-021-01303-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  47 in total

1.  Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.

Authors:  Georgios Petrides; Chitra Malur; Raphael J Braga; Samuel H Bailine; Nina R Schooler; Anil K Malhotra; John M Kane; Sohag Sanghani; Terry E Goldberg; Majnu John; Alan Mendelowitz
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

2.  Subcortical structures and cognitive dysfunction in first episode schizophrenia.

Authors:  Fengmei Fan; Hong Xiang; Shuping Tan; Fude Yang; Hongzhen Fan; Hua Guo; Peter Kochunov; Zhiren Wang; L Elliot Hong; Yunlong Tan
Journal:  Psychiatry Res Neuroimaging       Date:  2019-01-12       Impact factor: 2.376

3.  Olanzapine modulation of long- and short-range functional connectivity in the resting brain in a sample of patients with schizophrenia.

Authors:  Wenbin Guo; Feng Liu; Jindong Chen; Renrong Wu; Lehua Li; Zhikun Zhang; Jingping Zhao
Journal:  Eur Neuropsychopharmacol       Date:  2016-11-23       Impact factor: 4.600

4.  Olanzapine modulates the default-mode network homogeneity in recurrent drug-free schizophrenia at rest.

Authors:  Wenbin Guo; Feng Liu; Jindong Chen; Renrong Wu; Lehua Li; Zhikun Zhang; Huafu Chen; Jingping Zhao
Journal:  Aust N Z J Psychiatry       Date:  2017-06-12       Impact factor: 5.744

5.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Steven Ziebell; Ronald Pierson; Vincent Magnotta
Journal:  Arch Gen Psychiatry       Date:  2011-02

6.  Treatment effects of olanzapine on homotopic connectivity in drug-free schizophrenia at rest.

Authors:  Wenbin Guo; Feng Liu; Jindong Chen; Renrong Wu; Lehua Li; Zhikun Zhang; Huafu Chen; Jingping Zhao
Journal:  World J Biol Psychiatry       Date:  2017-07-11       Impact factor: 4.132

7.  Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine.

Authors:  Babak Khorram; Donna J Lang; Lili C Kopala; Robert A Vandorpe; Qing Rui; Vina M Goghari; Geoffrey N Smith; William G Honer
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness.

Authors:  Daniel Mamah; Michael P Harms; Deanna Barch; Martin Styner; Jeffrey A Lieberman; Lei Wang
Journal:  Front Psychiatry       Date:  2012-11-12       Impact factor: 4.157

Review 9.  Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis.

Authors:  John Lally; John Tully; Dene Robertson; Brendon Stubbs; Fiona Gaughran; James H MacCabe
Journal:  Schizophr Res       Date:  2016-01-27       Impact factor: 4.939

Review 10.  Efficacy and safety of treating patients with refractory schizophrenia with antipsychotic medication and adjunctive electroconvulsive therapy: a systematic review and meta-analysis.

Authors:  Wenzheng Wang; Chengcheng Pu; Jiangling Jiang; Xinyi Cao; Jijun Wang; Min Zhao; Chunbo Li
Journal:  Shanghai Arch Psychiatry       Date:  2015-08-25
View more
  2 in total

1.  Meta-analysis of structural and functional brain abnormalities in schizophrenia with persistent negative symptoms using activation likelihood estimation.

Authors:  Tingting Zhu; Zixu Wang; Chao Zhou; Xinyu Fang; Chengbing Huang; Chunming Xie; Honglin Ge; Zheng Yan; Xiangrong Zhang; Jiu Chen
Journal:  Front Psychiatry       Date:  2022-09-27       Impact factor: 5.435

2.  Temporoparietal Connectivity Within Default Mode Network Associates With Clinical Improvements in Schizophrenia Following Modified Electroconvulsive Therapy.

Authors:  Qiang Hu; Huan Huang; Yuchao Jiang; Xiong Jiao; Jie Zhou; Yingying Tang; Tianhong Zhang; Junfeng Sun; Dezhong Yao; Cheng Luo; Chunbo Li; Jijun Wang
Journal:  Front Psychiatry       Date:  2022-01-04       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.